Vyvanse 40 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FSJ29
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,351
Award facts
- Contract value 100% obligated
- $1,350.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,350.61 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, established on September 8, 2025, with a completion date of September 9, 2025, was awarded under firm fixed pricing with no set-aside designation, indicating competitive selection. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's substantial federal pharmaceutical procurement portfolio demonstrates the company's established capability to meet defense medical supply requirements through competitive federal contracting mechanisms.
Quick answers
Who was awarded contract SPE2DB25FSJ29?
SPE2DB25FSJ29 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FSJ29 worth?
The government has obligated $1,351 on SPE2DB25FSJ29.
Is contract SPE2DB25FSJ29 an order under another contract?
Yes. SPE2DB25FSJ29 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FSJ29 competed?
The extent of competition for SPE2DB25FSJ29 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award